Back to entry
Report this entry
Let us know what's wrong. We'll take a look and act if needed.
Optimi Health prices an oversubscribed US$15 million public offering and advances a Nasdaq uplisting to support growth in psychedelic pharmaceutical manufacturing
tradingview.com